Travelers over 60 advised to seek safer //vaccination alternatives . Individuals aged 60 and above are now being urged not to ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Key topics for discussion include Valneva's commercial stage vaccines and its differentiated portfolio of vaccine candidates, including VLA15, the world's leading Lyme disease vaccine candidate. VLA15 ...

While trade news drives short-term moves, US crypto legislation may influence BTC's longer-term supply-demand dynamics.

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

Infectious disease stocks stumbled in the early months of 2025, with the BioWorld Infectious Disease Index (BIDI) plunging 17.83% by the end of April, well behind the broader markets. By comparison, ...

The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Lyme disease and anaplasmosis, which both come from tick bites, are increasing significantly in Michigan over the past five years.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...